Optional text-derived evidence extracted beside the imported chart. Each signal stays traceable to source text.
No extracted signals for this patient
Reprocess an import with text enrichment to attach suggested evidence to this patient record.
Loading...
Most recent values are summarized here so the timeline can stay readable.
Loading...
Loading...
Recent chart, workflow, AI, cohort, and audit events shown in the user's local time.
40, more source rows below
Loading...
Recent Notes
Latest narrative evidence, clipped for scanning.
Loading...
Reports
Recent report headers and excerpts.
Loading...
Full Imported Source Data
Audit view for imported records. Kept collapsed so the working chart remains usable.
Loading...
PHM Worklist Actions
PHM saved action
PHM action: INFLUENZA_RECALL_DUE
status=needs_review | imported | next review=2026-07-17 | Review evidence for Influenza immunization recall; confirm appropriateness before contacting patient.
PHM saved action
PHM action: REPEATED_BP_ABOVE_TARGET
status=in_review | imported | outreach=email 2026-05-31 12:00 | next review=2026-06-16 | Review evidence for Repeated BP above target; confirm appropriateness before contacting patient.
PHM saved action
PHM action: UNCONTROLLED_HBA1C
status=new | imported | next review=2026-06-16 | Review evidence for HbA1c above target; confirm appropriateness before contacting patient.
Extracted signals
Latest Measurements
Select
There are no items to display.
0-0 of 0
Measure
Latest
Date
Previous
Trend
Hba1c
8.4 %
2026-03-18
7.8 %
+0.6
Systolic Bp
146 mmHg
2026-05-28
146 mmHg
0.0
Diastolic Bp
87 mmHg
2026-05-28
92 mmHg
-5.0
Bmi
26.2 kg/m2
2025-04-20
No previous
Reference
Egfr
46 mL/min/1.73m2
2024-12-17
48 mL/min/1.73m2
-2.0
Albumin Creatinine Ratio
58.2 mg/mmol
2025-10-14
No previous
Reference
Ldl Cholesterol
1.5 mmol/L
2026-03-10
2.5 mmol/L
-1.0
Fasting Glucose
8 mmol/L
2026-01-02
7.1 mmol/L
+0.9
Smoking Status
never smoker
2025-10-15
No previous
Reference
Page 1 / 1
Timeline
cohort_run
Cohort: Mental Health review cohort
completed | Chart evidence: Clinical note: SOAP note T2DM review. Home glucose pattern often elevated fasting. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk. | Clinical note: SOAP note Mental health review. PHQ-9 12, GAD-7 13. Sleep fragmented. No acute safety concern documented. Plan includes counselling resources, medication review, and follow-up interval based on symptoms. | Clinical note: SOAP note BP reviewed. Home readings above target several mornings. Reviewed sodium, adherence, and medication tolerance. | Clinical note: SOAP note Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports stable function. Plan: update labs/vitals and arrange follow-up as clinically indicated. | probable
cohort_run
Cohort: Smoking / Lung Screening review cohort
completed | Chart evidence: Care element: smoking_status never smoker form | probable
phm_workflow
PHM action: INFLUENZA_RECALL_DUE
status=needs_review | imported | next review=2026-07-17 | Review evidence for Influenza immunization recall; confirm appropriateness before contacting patient.
phm_workflow
PHM action: REPEATED_BP_ABOVE_TARGET
status=in_review | imported | outreach=email 2026-05-31 12:00 | next review=2026-06-16 | Review evidence for Repeated BP above target; confirm appropriateness before contacting patient.
phm_workflow
PHM action: UNCONTROLLED_HBA1C
status=new | imported | next review=2026-06-16 | Review evidence for HbA1c above target; confirm appropriateness before contacting patient.
clinical_flag
Influenza immunization recall
new | low | structured_fact | No recent influenza immunization evidence within the synthetic seasonal window.
clinical_flag
Repeated BP above target
new | high | structured_fact | Two recent BP readings are above target: 146/92 and 146/87 mmHg.
clinical_flag
Urine ACR overdue
new | medium | active_cohort_automation | Patient has diabetes and no recent urine ACR evidence within the synthetic monitoring window.
clinical_flag
HbA1c above target
new | high | structured_fact | Latest HbA1c 8.4% suggests above-target glycemic control and needs clinician review.
alert
Diabetes control flag: HbA1c above target
Generated from longitudinal lab trend.
note
SOAP note
T2DM review. Home glucose pattern often elevated fasting. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk.
appointment
chronic disease review
cancelled
note
SOAP note
Mental health review. PHQ-9 12, GAD-7 13. Sleep fragmented. No acute safety concern documented. Plan includes counselling resources, medication review, and follow-up interval based on symptoms.
note
SOAP note
BP reviewed. Home readings above target several mornings. Reviewed sodium, adherence, and medication tolerance.
SOAP note
T2DM review. Home glucose pattern often elevated fasting. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk.
SOAP note
Mental health review. PHQ-9 12, GAD-7 13. Sleep fragmented. No acute safety concern documented. Plan includes counselling resources, medication review, and follow-up interval based on symptoms.
SOAP note
BP reviewed. Home readings above target several mornings. Reviewed sodium, adherence, and medication tolerance.
SOAP note
Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports stable function. Plan: update labs/vitals and arrange follow-up as clinically indicated.
Consult
Eye care report: macular degeneration reviewed. Follow-up interval documented; no urgent ocular change in this synthetic report.
Laboratory
Creatinine/eGFR and urine albumin-creatinine ratio reviewed for chronic kidney disease monitoring.
Laboratory
HbA1c, fasting glucose, lipid panel, creatinine/eGFR, and urine ACR reviewed for diabetes follow-up.
Patient Context
ProviderJuliana Davies
LanguageFarsi
PhoneMissing
Emailmichael.taylor30@example.test
Sourcestructured_json
Review tasks
Influenza immunization recall
No recent influenza immunization evidence within the synthetic seasonal window.
completed | Chart evidence: Clinical note: SOAP note T2DM review. Home glucose pattern often elevated fasting. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk. | Clinical note: SOAP note Mental health review. PHQ-9 12, GAD-7 13. Sleep fragmented. No acute safety concern documented. Plan includes counselling resources, medication review, and follow-up interval based on symptoms. | Clinical note: SOAP note BP reviewed. Home readings above target several mornings. Reviewed sodium, adherence, and medication tolerance. | Clinical note: SOAP note Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports stable function. Plan: update labs/vitals and arrange follow-up as clinically indicated. | probable
cohort_run
Cohort: Smoking / Lung Screening review cohort
completed | Chart evidence: Care element: smoking_status never smoker form | probable
phm_workflow
PHM action: INFLUENZA_RECALL_DUE
status=needs_review | imported | next review=2026-07-17 | Review evidence for Influenza immunization recall; confirm appropriateness before contacting patient.
phm_workflow
PHM action: REPEATED_BP_ABOVE_TARGET
status=in_review | imported | outreach=email 2026-05-31 12:00 | next review=2026-06-16 | Review evidence for Repeated BP above target; confirm appropriateness before contacting patient.
phm_workflow
PHM action: UNCONTROLLED_HBA1C
status=new | imported | next review=2026-06-16 | Review evidence for HbA1c above target; confirm appropriateness before contacting patient.
clinical_flag
Influenza immunization recall
new | low | structured_fact | No recent influenza immunization evidence within the synthetic seasonal window.
clinical_flag
Repeated BP above target
new | high | structured_fact | Two recent BP readings are above target: 146/92 and 146/87 mmHg.
clinical_flag
Urine ACR overdue
new | medium | active_cohort_automation | Patient has diabetes and no recent urine ACR evidence within the synthetic monitoring window.
clinical_flag
HbA1c above target
new | high | structured_fact | Latest HbA1c 8.4% suggests above-target glycemic control and needs clinician review.
alert
Diabetes control flag: HbA1c above target
Generated from longitudinal lab trend.
care_element
systolic_bp
care_element
diastolic_bp
note
SOAP note
T2DM review. Home glucose pattern often elevated fasting. Discussed nutrition, exercise, foot care, and medication adherence. Plan: repeat HbA1c and review cardiovascular/renal risk.
appointment
chronic disease review
cancelled
care_element
hba1c
care_element
ldl_cholesterol
care_element
fasting_glucose
note
SOAP note
Mental health review. PHQ-9 12, GAD-7 13. Sleep fragmented. No acute safety concern documented. Plan includes counselling resources, medication review, and follow-up interval based on symptoms.
care_element
smoking_status
never smoker
care_element
albumin_creatinine_ratio
note
SOAP note
BP reviewed. Home readings above target several mornings. Reviewed sodium, adherence, and medication tolerance.
appointment
lab follow-up
no_show
report
Consult
Eye care report: macular degeneration reviewed. Follow-up interval documented; no urgent ocular change in this synthetic report.
care_element
systolic_bp
care_element
diastolic_bp
care_element
bmi
report
Laboratory
Creatinine/eGFR and urine albumin-creatinine ratio reviewed for chronic kidney disease monitoring.
report
Laboratory
HbA1c, fasting glucose, lipid panel, creatinine/eGFR, and urine ACR reviewed for diabetes follow-up.
care_element
hba1c
care_element
egfr
care_element
fasting_glucose
care_element
hba1c
care_element
immunization
Influenza vaccine documented
care_element
diastolic_bp
care_element
systolic_bp
care_element
ldl_cholesterol
note
SOAP note
Follow-up visit. Medication list reviewed, allergies checked, and preventive care status discussed. Patient reports stable function. Plan: update labs/vitals and arrange follow-up as clinically indicated.